SymbioCellTech, LLC
Salt Lake City, UT, US· latest recorded location
SymbioCellTech, LLC is named on 3 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 5
- Inventors
- 4
- Granted in 2026 so far
- 1
- Most recent grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 8 documents
Recent patents
- Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith6 Oct 2026US 12,753,392 B2
- Adaptation of hollow-fiber-based cell culture technology for the manufacturing of (1) neo-islets, employed for the treatment of type 1 and type 2 diabetes mellitus, and (2) the generation of exosomes from various cell types, used in the treatment of different organ injuries and diseases22 Apr 2025US 12,281,330 B2
- Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith1 Nov 2022US 11,485,954 B2
- Species-Specific Tissue Culture Medium for the Propagation of Cells23 Jul 2026US 2026/0209710 A1
- Cell Clusters Comprising Stem and Islet Cells, Methods of Making, and Treatment of Diabetes Mellitus Therewith14 Mar 2024US 2024/0084261 A1
- Neo-Islets Comprising Stem and Islet Cells and Treatment of Diabetes Mellitus Therewith2 Feb 2023US 2023/0033991 A1
- Adaptation of Hollow-Fiber-Based Cell Culture Technology for the Manufacturing of (1) Neo-Islets, Employed for the Treatment of Type 1 and Type 2 Diabetes Mellitus, and (2) the Generation of Exosomes from Various Cell Types, Used in the Treatment of Different Organ Injuries and Diseases2 Jul 2020US 2020/0208115 A1
- Neo-islets comprising stem and islet cells and treatment of diabetes mellitus therewith16 Mar 2017US 2017/0073641 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.